ResMed Inc. (ASX:RMD) announces US$750 million SaaS acquisition: Should you invest?

Healthcare star ResMed Inc. (ASX:RMD) has announced a US$750 million SaaS acquisition. Should you buy shares?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc. (ASX: RMD) share price hasn't been able to follow the rest of the market higher on Tuesday.

The medical device company's shares are down almost 1% to $14.50 despite the announcement of a major acquisition.

What has ResMed acquired?

According to this morning's release, ResMed has signed a definitive agreement to acquire MatrixCare for US$750 million. The company will fund the acquisition primarily with its credit facility.

MatrixCare is a leader in U.S. long-term post-acute care software. It serves more than 15,000 providers across skilled nursing, life plan communities, senior living and private duty.

In calendar year 2018, MatrixCare's pro forma net revenue is estimated to be approximately US$122 million, with a pro forma EBITDA of approximately US$30 million.

This means that the purchase price represents a valuation multiple of MatrixCare's 25x the expected calendar year 2018 pro forma EBITDA. It is expected to close by the end of the second quarter.

Management expects the transaction will be immediately accretive to non-GAAP gross margin and non-GAAP diluted earnings per share after completion and beyond.

Why has it acquired MatrixCare?

Management believes that MatrixCare's offering is complementary to ResMed's current software-as-a-service (SaaS) offerings in home medical equipment, home health and hospice, delivered through Brightree and HEALTHCAREfirst.

The release explains that Minnesota-based MatrixCare's electronic health record (EHR) solution supports a wide range of long-term care settings which allows providers to increase patient management efficiencies and deliver superior clinical care. This includes point of care, lead and referral management, claims processing, payroll and nutrition management, among others.

ResMed's CEO, Mick Farrel, appeared pleased to have snared the fast-growing company.

He said: "The acquisition of MatrixCare is an excellent addition to the out-of-hospital software portfolio that we can offer our healthcare provider customers. ResMed is the world's leading tech-driven medical device company and is well positioned to be the leading out-of-hospital software provider in the market. With our portfolio including Brightree, HEALTHCAREfirst, and MatrixCare, we will streamline transitions of care, creating better outcomes for patients, caregivers, and out-of-hospital healthcare providers."

Should you invest?

While ResMed has paid a significant premium for MatrixCare, I believe its strong growth prospects makes it worthy of the price tag.

Overall, I think this deal further enhances ResMed's growth profile, making it a great buy and hold investment option along with fellow healthcare stars Cochlear Limited (ASX: COH) and CSL Limited (ASX: CSL).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

ASX shares Business man marking buy on board and underlining it
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Man ponders a receipt as he looks at his laptop.
Technology Shares

Brokers rerate 3 leading ASX 200 tech stocks

Experts reveal their ratings on the ASX 200 tech sector's three biggest companies.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why Brightstar, Eagers Automotive, Regis Resources, and Westpac shares are sinking

These shares are starting the week in the red. But why?

Read more »

growth charts with small cap written on a sticky note
Small Cap Shares

Expert names 3 ASX small-cap stocks to buy in July

ASX small-cap stocks have greater ability to generate outsized returns, but can be difficult to discover.

Read more »

A young couple hug each other and smile at the camera standing in front of their brand new luxury car
Share Market News

Are CAR Group shares a buy ahead of reporting season?

Will CAR Group shares take off from here?

Read more »

Worker on a laptop at an oil and gas pipeline.
Broker Notes

How much upside does Macquarie predict for Santos shares?

Let’s find out what the broker says.

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.
Broker Notes

Does Macquarie rate REA Group shares a buy, hold or sell?

Let's have a look at what the broker thinks.

Read more »